Article abstract


Nature Immunology 10, 744 - 752 (2009)
Published online: 31 May 2009 | doi:10.1038/ni.1742

The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon

Chen Wang1,2, Taoyong Chen1,2, Jia Zhang1, Mingjin Yang1, Nan Li1, Xiongfei Xu1 & Xuetao Cao1


E3 ubiquitin ligases are important in both innate and adaptive immunity. Here we report that Nrdp1, an E3 ubiquitin ligase, inhibited the production of proinflammatory cytokines but increased interferon-beta production in Toll-like receptor–triggered macrophages by suppressing adaptor MyD88–dependent activation of transcription factors NF-kappaB and AP-1 while promoting activation of the kinase TBK1 and transcription factor IRF3. Nrdp1 directly bound and polyubiquitinated MyD88 and TBK1, which led to degradation of MyD88 and activation of TBK1. Knockdown of Nrdp1 inhibited the degradation of MyD88 and the activation of TBK1 and IRF3. Nrdp1-transgenic mice showed resistance to lipopolysaccharide-induced endotoxin shock and to infection with vesicular stomatitis virus. Our data suggest that Nrdp1 functions as both an adaptor protein and an E3 unbiquitin ligase to regulate TLR responses in different ways.

Top
  1. National Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai, China.
  2. These authors contributed equally to this work.

Correspondence to: Xuetao Cao1 e-mail: caoxt@public3.sta.net.cn



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

TRIM-ing down Tolls

Nature Immunology News and Views (01 Apr 2008)

DUBbing down innate immunity

Nature Immunology News and Views (01 Oct 2004)

See all 6 matches for News And Views

Extra navigation

Subscribe to Nature Immunology

Subscribe

Open Innovation Challenges

naturejobs

ADVERTISEMENT